- ►hamilton.edu [PDF] E Gaggelli, H Kozlowski, D Valensin, G … - Chem. Rev, 2006 - pubs.acs.org Gianni Valensin (born 1946) received his degree in Chemistry from the University
of Florence, Italy, in 1970. He was appointed Full Professor of Physical
Chemistry in 1986 at the University of Basilicata, Italy, and, later, Full ... Cited by 104 - Related articles - All 8 versions
- ►kuleuven.be [PDF] B Cauwe, PE Van den Steen, G Opdenakker - Critical reviews in biochemistry and molecular biology, 2007 - informahealthcare.com Matrix metalloproteinases (MMPs) constitute a family of more than 20
endopeptidases. Identification of specific matrix and non-matrix components as
MMP substrates showed that, aside from their initial role as extracellular ... Cited by 69 - Related articles - BL Direct - All 7 versions
JE Vance, H Hayashi, B Karten - Seminars in Cell and Developmental Biology, 2005 - Elsevier Cholesterol is highly enriched in the brain compared to other tissues.
Essentially all cholesterol in the brain is synthesized endogenously since
plasma lipoproteins are unable to cross the blood–brain barrier. ... Cited by 67 - Related articles - All 3 versions
RA Fuentealba, G Farias, J Scheu, M … - Brain Research Reviews, 2004 - Elsevier Alzheimer's disease (AD) is a neurodegenerative disorder with progressive
dementia accompanied by two main structural changes in the brain: intracellular
protein deposits termed neurofibrillary tangles (NFT) and extracellular ... Cited by 66 - Related articles - All 3 versions
- ►jbc.org ML Hemming, DJ Selkoe - Journal of Biological Chemistry, 2005 - ASBMB Human genetic data have associated angiotensin-converting enzyme (ACE) with
Alzheimer disease (AD), and purified ACE has been reported to cleave synthetic
amyloid -protein (A ) in vitro. Whether deficiency in ACE activity, arising ... Cited by 67 - Related articles - BL Direct - All 7 versions
R Cacabelos - Methods Mol Biol, 2008 - Springer Summary Pharmacological treatment in Alzheimer's disease (AD) accounts for
10–20% of direct costs, and fewer than 20% of AD patients are moderate
responders to conventional drugs (donepezil, rivastigmine, galantamine, ... Cited by 50 - Related articles - All 8 versions
- ►fasebj.org [PDF] H Qing, W Zhou, MA Christensen, X Sun, Y … - The FASEB Journal, 2004 - FASEB The FASEB Journal express article 10.1096/fj.04-1994fje. Published online August
2, 2004. ... Degradation of BACE by the ubiquitin-proteasome pathway ... Hong
Qing,* Weihui Zhou,* Michelle A. Christensen,* Xiulian Sun, Cited by 43 - Related articles - BL Direct - All 5 versions
- ►jbc.org CG Evans, S Wisen, JE Gestwicki - Journal of Biological Chemistry, 2006 - ASBMB Alzheimer disease is a neurological disorder that is characterized by the
presence of fibrils and oligomers composed of the amyloid (A ) peptide. In
models of Alzheimer disease, overexpression of molecular chaperones, ... Cited by 39 - Related articles - All 8 versions
W Zhang, S Oya, MP Kung, C Hou, DL Maier, … - Nuclear medicine and biology, 2005 - Elsevier Accumulation of β-amyloid (Aβ) plaques in the brain is believed to be one of
the most significant factors associated with the development of Alzheimer's
disease (AD) [1]. Therefore, developing Aβ plaque-specific probe for in ... Cited by 36 - Related articles - All 8 versions
WA Campbell, H Yang, H Zetterberg, S Baulac … - Journal of neurochemistry, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 35 - Related articles - BL Direct - All 5 versions
